SCHEMBL29655416

SCHEMBL29655416

CCCCOC(=O)N1CC(CCO)C1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ GBA2 Q9HCG7 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.40
▸ ATM Q13315 1/20 0.38
▸ HPGD P15428 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HRH2 P25021 1/20 0.36
▸ HRH1 P35367 1/20 0.36
▸ BCHE P06276 1/20 0.35
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ ACHE P22303 6/20 0.34
▸ HCAR2 Q8TDS4 1/20 0.34
▸ NAAA Q02083 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30380124 0.88 LMNA (0.49) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL4968757 0.87 LMNA (0.53) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL30678922 0.86 SMN1; SMN2 (0.47) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL7448604 0.84 LMNA (0.55) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL4968751 0.83 LMNA (0.53) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL30129908 0.82 LMNA (0.51) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL30129902 0.82 LMNA (0.51) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL31282074 0.81 LMNA (0.44) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL30075951 0.81 LMNA (0.44) LMNAPOLBSMN1; SMN2GBA2ALDH1A1
SCHEMBL30075784 0.80 LMNA (0.43) LMNAPOLBSMN1; SMN2GBA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4097096-A2 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2022-12-07 — — EP disclosed
WO-2022096930-A2 NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS, AND USES THEREOF ILDONG PHARMACEUTICAL CO., LTD. (KR) 2022-05-12 — — WO disclosed
Send feedback